Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Qkine is a specialist developer and manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications
Xerion Healthcare is the technology commercialization company of University of Oxford.
BibliU provides colleges and universities with digital content management, automation, and an analytics platform.
Opsydia is set to disrupt a number of industries by its ability to create practically invisible structures inside transparent materials.
iKVA is an AI knowledge management company that helps users with data analytics and decision making solutions.
DIOSynVax is new technology that will significantly accelerate vaccine development and achieve dramatic improvements.
Helio Display Materials offers foundational materials for the new wave of display innovation driven by color conversion.
Semarion leverages microfabrication technology to build smart materials and develop novel cell assaying applications.
Pathfinder is developing a novel catheter based system that provides a better way for patients to receive haemodialysis for kidney failure.
8power is a University of Cambridge start-up developing novel technology for sensing and measurement in industrial applications.
Charco Neurotech is a medical technology company that develops non-invasive wearable devices.
PetMedix is a pet therapeutics startup.
Lumenisity is developing advanced cable solutions to address the need for massive bandwidth increases in high capacity system.
Carbometrics is a specialist chemistry company to help people with diabetes to live more normal and longer lives.
1715Labs is a company being established to commercialise Zooniverse technology.
Sorex Sensors manufactures high sensitivity MEMS mass sensors to transform industrial and consumer products.
Flusso is a semiconductor company that develops and manufactures sensor solutions for various industries.
AudioTelligence delivers real-time audio processing technology for the enhancement of automatic speech recognition (ASR) systems.
PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.
Oxford PV is a provider of perovskite solar cells.
Istesso is a drug discovery and development company working in the field of immunometabolism.
Spectral Edge combines patented Image Fusion tech with Deep Learning to reveal more of the color, detail and clarity in any image.
Developing SRD® technology for a low-power display of vivid colours that doesn’t look washed out in bright conditions
Jukedeck is developing an artificially intelligent music composer.
Parkwalk Advisors has invested in 173 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Parkwalk Advisors's top investment sectors include Biotechnology, Information Technology, Health Care, Manufacturing, Electronics. The firm invests across 36 different industry categories.
Among tracked funding rounds, Oxford PV received $42.8M in a Series D round. Parkwalk Advisors's total known invested capital is $1.8B.
Parkwalk Advisors's average investment size is $12.2M across its portfolio of 173 companies.
Recent Parkwalk Advisors portfolio additions include Qkine, Xerion Healthcare, BibliU, Opsydia, iKVA. These companies were founded in 2020 or later.